The temporary restraining order prohibits President Donald Trump’s administration from withholding federal funding allocated by Congress.

The stock's fall snapped a two-day winning streak.

Cardinal Health’s acquisition of Advanced Diabetes Supply Group hasn’t closed yet, but company officials said on a conference call to discuss second quarter financial results that ...

TD Cowen raised the firm’s price target on Cardinal Health (CAH) to $150 from $144 and keeps a Buy rating on the shares. The firm said they ...

Q2 2025 Earnings Call Transcript January 30, 2025 Cardinal Health, Inc. beats earnings expectations. Reported EPS is $1.93, ...

Mizuho Securities analyst Steven Valiquette has reiterated their bullish stance on CAH stock, giving a Buy rating yesterday.Invest with ...

Cardinal Health (NYSE:CAH – Get Free Report) had its target price hoisted by equities researchers at Wells Fargo & Company from $127.00 to $135.00 in a research note issued on Wednesday,Benzinga ...

Jan 30 (Reuters) - Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast as strong ...

Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast as strong demand for costly specialty medicines and branded drugs drove sales at its pharmaceuticals unit.

"The addition at Scioto High School is funded with resources that have already been approved by our voters," Marschhausen ...

Q2 2025 Management View CEO Jason Hollar emphasized strong Q2 performance driven by robust demand in Pharmaceutical and ...

Hello, and welcome to the Second Quarter Fiscal Year 2025 Cardinal Health Inc. Earnings Conference Call. My name is George, and I'll be coordinator for today's event. Please note, this conference is ...